CDKN2A and cancer: The status of CDKN2A/B was further confirmed with cancer genome profiling (CGP) test in 12 cases (7 cases were analyzed with FoundationOne®CDx and 5 cases were analyzed with OncomineTM Childhood Cancer Research Assay).